Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma

Clinical trial NCT02169609 · COMPLETED

Trial details

NCT number: NCT02169609
Sponsor: Fundació Sant Joan de Déu
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroblastoma Neoplasm, Residual Effects of Immunotherapy

Start date: 2014-11-26
Primary completion: 2016-12-26
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.